Unbiased Outcome Estimates from Conservative vs. Aggressive Treatment of Early Stage Prostate Cancer from Retrospective Data: An Instrumental Variables Approach

Abstract

Instrumental variables (IV) techniques were used to estimate outcome differences between treatment options among marginal patients with early stage prostate cancer diagnosed during 1986-1993. Access to care, area socioeconomic and healthcare market characteristics affected choice of treatment and these associations varied among age groups. Unbiased estimates of treatment effects also varied among these age groups. Results suggest that an increase in aggressive treatment for patients with presumed localized early stage prostate cancer would have resulted in increased survival rates but these effects decreased with patient age. Further, an increase in surgery among those patients aggressively treated would have also increased survival and these effects increased with patient age. health policy should be tailored to these differences between age subgroups of older men. Though results suggested that increased aggressive treatment in general, and surgery in particular, would have been cost-effective, conclusions about cost-effectiveness are tenuous because Medicare costs were available only from 1991-93.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 01, 2002
Accession Number
ADB283537

Entities

People

  • Elizabeth A. Chrischilles
  • John Brooks
  • Shane Scott
  • Shari Chen-hardee
  • Tae-ryong Park

Organizations

  • University of Iowa

Tags

DTIC Thesaurus Topics

  • Age Groups
  • Biomedical Research
  • Communication Channels
  • Cost Effectiveness
  • Cost Estimates
  • Costs
  • Databases
  • Diseases And Disorders
  • Geographic Regions
  • Health Care
  • Health Services
  • Medical Personnel
  • Neoplasms
  • Probability
  • Prostate Cancer
  • Therapy
  • Urban Areas

Fields of Study

  • Medicine

Readers

  • Brain and Cognitive Science; Experimental Psychology; Cognitive Neuroscience
  • Medical or Health Care Field.
  • Molecular and genetic basis of cancer.